1. Prevention from radiation damage by natural products
    Nicolas Fischer et al, 2017, Phytomedicine CrossRef
  2. Occurrence of pneumonitis following radiotherapy of breast cancer - A prospective study.
    Danijela Vasiljevic et al, 2018, Strahlenther Onkol CrossRef
  3. Integrated Cancer Treatment in the Course of Metastatic Pancreatic Cancer: Complete Resolution in 2 Cases
    Massimo Bonucci et al, 2018, Integr Cancer Ther CrossRef
  4. Melatonin disturbs SUMOylation-mediated crosstalk between c-Myc and nestin via MT1 activation and promotes the sensitivity of paclitaxel in brain cancer stem cells.
    Hyemin Lee et al, 2018, J Pineal Res CrossRef
  5. The Role of Curcumin in Prevention and Management of Metastatic Disease
    Beatrice Bachmeier et al, 2018, IJMS CrossRef
  6. The association between p53 protein phosphorylation at serine 15, serine 20 and sensitivity of cells isolated from patients with ovarian cancer and cell lines to chemotherapy in in vitro study
    Iwona Kamińska et al, 2018, Pharmacological Reports CrossRef
  7. Integrative Medizin bei Patientinnen mit Ovarialkarzinomen
    Karsten Münstedt et al, 2018, Onkologe CrossRef
  8. Lectins as possible tools for improved urinary bladder cancer management
    Tanja Višnjar et al, 2019 CrossRef
  9. The Preparation, Determination of a Flexible Complex Liposome Co-Loaded with Cabazitaxel and β-Elemene, and Animal Pharmacodynamics on Paclitaxel-Resistant Lung Adenocarcinoma
    Yi-Ying Zeng et al, 2019, Molecules CrossRef
  10. Development of β-elemene and Cisplatin Co-Loaded Liposomes for Effective Lung Cancer Therapy and Evaluation in Patient-Derived Tumor Xenografts
    Mingxiang Cao et al, 2019, Pharm Res CrossRef
  11. Curcumin: footprints on cardiac tissue engineering
    Saeid Kargozar et al, 2019, Expert Opinion on Biological Therapy CrossRef
  12. Chemical characterization of the main bioactive polyphenols from the roots of Morus australis (mulberry)
    Sen Guo et al, 2019, Food Funct. CrossRef
  13. Morphological and Functional State of Liver under the Impact of Paclitaxel and Cisplatin in the Experiment
    S. B. Herashchenko et al, 2019, Ukr. ž. med. bìol. sportu CrossRef
  14. Recent advances in molecular diagnostics and therapeutic targets for pancreatic cancer
    Ryan Clay et al, 2019 CrossRef
  15. circCELSR1 (hsa_circ_0063809) Contributes to Paclitaxel Resistance of Ovarian Cancer Cells by Regulating FOXR2 Expression via miR-1252
    Shu Zhang et al, 2020, Molecular Therapy - Nucleic Acids CrossRef
  16. Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer.
    Teodora Costea et al, 2020, Int J Mol Sci CrossRef
  17. The Cytoprotective and Anti-cancer Potential of Bisbenzylisoquinoline Alkaloids from Nelumbo nucifera
    Prasath Manogaran et al, 2020, CTMC CrossRef
  18. Inhibition of Cancer Stem-Like Phenotype by Curcumin and Deguelin in CAL-62 Anaplastic Thyroid Cancer Cells.
    Mehmet A Kocdor et al, 2019, Anticancer Agents Med Chem CrossRef
  19. Functionalized Alpha‐lactalbumin Conjugated with Gold Nanoparticle for Targeted Drug Delivery
    Manik N. Waghmare et al, 2020, ChemistrySelect CrossRef
  20. Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1
    Xiaohui Li et al, 2020, Cancer Biology & Therapy CrossRef
  21. Human serum albumin-based dual-agent delivery systems for combination therapy: acting against cancer cells and inhibiting neovascularization in the tumor microenvironment
    Zhenlei Zhang et al, 2020, Mol. Pharmaceutics CrossRef
  22. Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant
    Elaine C. D. Gonçalves et al, 2020, Molecules CrossRef
  23. Efficacy and safety of curcumin in combination with paclitaxel in patients with advanced, metastatic breast cancer: A comparative, randomized, double-blind, placebo-controlled clinical trial
    Tatul Saghatelyan et al, 2020, Phytomedicine CrossRef
  24. Curcumin effect on cancer cells' multidrug resistance: An update
    Saeedeh Keyvani‐Ghamsari et al, 2020, Phytotherapy Research CrossRef
  25. Curcumin-human serum albumin nanoparticles decorated with PDL1 binding peptide for targeting PDL1-expressing breast cancer cells
    Zahra Hasanpoor et al, 2020, International Journal of Biological Macromolecules CrossRef
  26. Targeting miRNAs by natural products: A new way for cancer therapy
    Beilei Zhang et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  27. Osteolytic metastasis in breast cancer: effective prevention strategies.
    Chandi Charan Mandal, 0 CrossRef
  28. Ginsenoside 3β-O-Glc-DM (C3DM) enhances the antitumor activity of Taxol on Lewis lung cancer by targeting the interleukin-6/Jak2/STAT3 and interleukin-6/AKT signaling pathways
    Mei Tang et al, 2020, World J Tradit Chin Med CrossRef
  29. Dracocephalum palmatum Stephan extract induces apoptosis in human prostate cancer cells via the caspase-8-mediated extrinsic pathway
    Se-Eun LEE et al, 2020, Chinese Journal of Natural Medicines CrossRef
  30. Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3K/Akt/mTOR pathway: go four better to treat bladder cancer
    Khushbukhat Khan et al, 2020, Cancer Cell Int CrossRef
  31. Therapeutic potential of p53 reactivation in cervical cancer
    Xiangxuan Zhao et al, 2020, Critical Reviews in Oncology/Hematology CrossRef
  32. Targeting Major Signaling Pathways of Bladder Cancer with Phytochemicals: A Review
    Connor Chestnut et al, 2020, Nutrition and Cancer CrossRef
  33. Toward Hijacking Bioelectricity in Cancer to Develop New Bioelectronic Medicine
    Andie J. Robinson et al, 2021, Adv. Therap. CrossRef
  34. Immunoconjugates as immune canoes to kill breast cancer cells
    Mariana Segovia-Mendoza et al, 2021 CrossRef
  35. Synergistic effects of green tea extract and paclitaxel in the induction of mitochondrial apoptosis in ovarian cancer cell lines
    Mohammad Panji et al, 2021, Gene CrossRef
  36. Curcumin reverses doxorubicin resistance in colon cancer cells at the metabolic level
    Nan Zhang et al, 2021, Journal of Pharmaceutical and Biomedical Analysis CrossRef
  37. The Pharmacokinetics and Bio-distribution Studied by Simultaneous Analysis of Curcumin and Paclitaxel in Biosamples
    Chao Pi et al, 2021, Chromatographia CrossRef
  38. Self-assembled micelles of the (lipo) glycopeptides, teicoplanin, as taxane nanocarriers
    Laura Raquel Comini et al, 2021, Nanotechnology CrossRef
  39. A Review on Drug Delivery System for Tumor Therapy
    Guoxiang Liu et al, 2021, Front. Pharmacol. CrossRef
  40. Shifting of cell cycle arrest from the S‐phase to G2/M phase and downregulation of EGFR expression by phytochemical combinations in HeLa cervical cancer cells
    Sarita Pani et al, 2021, J Biochem Mol Toxicol CrossRef
  41. Preparation of antibodies against TXR1 and construction of a new DNA tumor vaccine
    Yuanjie Sun et al, 2022, International Immunopharmacology CrossRef
  42. Negative pressure cavitation fractional precipitation for the purification of paclitaxel from Taxus chinensis
    Hye-Su Min et al, 2022, Korean J. Chem. Eng. CrossRef
  43. An overview of the therapeutic effects of curcumin in reproductive disorders with a focus on the antiinflammatory and immunomodulatory activities
    Bita Saifi et al, 2022, Phytotherapy Research CrossRef
  44. Acquisition of paclitaxel resistance modulates the biological traits of gastric cancer AGS cells and facilitates epithelial to mesenchymal transition and angiogenesis
    Ali Niapour et al, 2022, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
  45. Smart releasing CuS/ZnS nanocomposite dual drug carrier and photothermal agent for use as a theranostic tool for cancer therapy
    Aishwarya Shetty et al, 2022, Journal of Drug Delivery Science and Technology CrossRef
  46. The Under appreciated Role of Lifestyle and Nutrition in Cancer Prevention, Genesis, and Treatment
    null Umesh C. Gupta et al, 2018, J. Can. Res. Updates CrossRef
  47. Synergistic co-administration of docetaxel and curcumin to chemoresistant cancer cells using PEGylated and RIPL peptide-conjugated nanostructured lipid carriers
    Chang Hyun Kim et al, 2022, Cancer Nano CrossRef
  48. The Potential of Natural Products in the Treatment of Triple-Negative Breast Cancer.
    Danny Yu Jia Ke et al, 2021, Curr Cancer Drug Targets CrossRef
  49. Role of inflammation and oxidative stress in chemotherapy-induced neurotoxicity
    Pooja Gupta et al, 2022, Immunol Res CrossRef
  50. Curcumin Upregulates miR-148a to Increase the Chemosensitivity of CD44-Positive Prostate Cancer Stem Cells to Paclitaxel Through Targeting the MSK1/IRS1 axis
    Mohammad Amin Vatankhah et al, 2022, Drug Res (Stuttg) CrossRef
  51. Alternative Therapies for Chemotherapy-Induced Peripheral Neuropathy
    Qiliang Maoying et al, 2022 CrossRef
  52. Anti-Neuroinflammatory Potential of Polyphenols by Inhibiting NF-κB to Halt Alzheimer's Disease
    Md. Sahab Uddin et al, 2021, CPD CrossRef
  53. Paclitaxel and Curcumin as Dual-Drug-Loaded Lipid Nanocapsules in the Management of Brain Tumour
    Mahfoozur Rahman et al, 2022, J Clust Sci CrossRef
  54. Bioelectronic medicines: Therapeutic potential and advancements in next-generation cancer therapy
    Arun Kumar Singh et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  55. Enhancement of Anti-Tumoral Properties of Paclitaxel Nano-Crystals by Conjugation of Folic Acid to Pluronic F127: Formulation Optimization, In Vitro and In Vivo Study
    Nagaraja Sreeharsha et al, 2022, Molecules CrossRef
  56. Nanocarriers for delivery of taxanes: A review on physicochemical and biological aspects
    Bruno Rodrigues Arruda et al, 2022, Journal of Drug Delivery Science and Technology CrossRef
  57. Synthesis of Carrier-Free Paclitaxel–Curcumin Nanoparticles: The Role of Curcuminoids
    Sena Karaosmanoglu et al, 2022, Bioengineering CrossRef
  58. Recent Developments and Anticancer Therapeutics of Paclitaxel: An Update
    Anees Ahmed Khalil et al, 2022, CPD CrossRef
  59. Curcumin enhances the anti-cancer efficacy of paclitaxel in ovarian cancer by regulating the miR-9-5p/BRCA1 axis
    Yuwan Liu et al, 2023, Front. Pharmacol. CrossRef
  60. 4-methylthiobutyl isothiocyanate synergize the antiproliferative and pro-apoptotic effects of paclitaxel in human breast cancer cells
    Harneetpal Kaur et al, 2023, Biotechnology and Genetic Engineering Reviews CrossRef
  61. Curcumin: a natural organic component that plays a multi-faceted role in ovarian cancer
    Xiaoping Liu et al, 2023, J Ovarian Res CrossRef
  62. Smart Releasing CuS/ZnS Nanocomposite Dual Drug Carrier and Photothermal Agent for Use as a Theranostic Tool for Cancer Therapy
    Aishwarya Shetty et al, 2021, SSRN Journal CrossRef
  63. Construction of Curcumin and Paclitaxel Co-Loaded Lipid Nano Platform and Evaluation of Its Anti-Hepatoma Activity in vitro and Pharmacokinetics in vivo
    Yuxun Wei et al, 2023, IJN CrossRef
  64. Microwave‐Assisted Synthesis of Porous Biomolecule‐Incorporated Metal‐Organic Frameworks as Efficient Nanocarriers for Anti‐Cancer Drugs
    Trang Thi Thu Nguyen et al, 2023, ChemistrySelect CrossRef
  65. Epigenetic drugs as new emerging therapeutics: What is the scale's orientation of application and challenges?
    Marzieh Ramezani Farani et al, 2023, Pathology - Research and Practice CrossRef
  66. Stimuli-responsive (nano)architectures for phytochemical delivery in cancer therapy
    Mohammad Arad Zandieh et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  67. Cancer Therapeutics: Mechanism of Action, Radiation Toxicity, and Drug Formulation
    Durgesh Singh et al, 2023 CrossRef
  68. Research Advances in Clinical Applications, Anticancer Mechanism, Total Chemical Synthesis, Semi-Synthesis and Biosynthesis of Paclitaxel
    Shengnan Zhang et al, 2023, Molecules CrossRef
  69. Nanotechnology and Cancer Bioelectricity: Bridging the Gap Between Biology and Translational Medicine
    Rosalia Moreddu, 2023, Advanced Science CrossRef
  70. Neuroprotective effect of 2-ethyl-6-methyl-3-hydroxypyridine succinate on the sciatic nerve and its segmental centers in experimental paclitaxel-induced peripheral neuropathy
    S. B. Herashchenko et al, 2023, Rep. of Morph. CrossRef
  71. Effects of Ultrasound Contrast Agent-Encapsulated Paclitaxel Extract on the Proliferation and Invasion Ability of Hepatocellular Carcinoma Cells
    Duanji Deng et al, 2023, sci adv mater CrossRef
  72. Inhalable paclitaxel nanoagglomerate dry powders for lung cancer chemotherapy: Design of experiments-guided development, characterization and in vitro evaluation
    Ho Wan Chan et al, 2024, International Journal of Pharmaceutics CrossRef
  73. Phytochemical and Biological Properties of Anticancer Medicinal Plants From India
    Babi Lakkoju et al, 2024 CrossRef
  74. An insight into the dual role of MoS2-based nanocarriers in anticancer drug delivery and therapy
    Sandip Ghosh et al, 2024, Acta Biomaterialia CrossRef
  75. The Advancement of Molybdenum Disulfide Quantum Dots Nanoparticles as Nanocarrier for Drug Delivery Systems: Cutting-edge in Dual Therapeutic Roles
    MohammadHossein Karami et al, 2024, Journal of Molecular Structure CrossRef
  76. β-d-Ribofuranose as a Core with a Phosphodiester Moiety as the Enzyme Recognition Site for Codrug Development
    Jih Ru Hwu et al, 2024, Org. Lett. CrossRef